4
Changes in Ownership
FATE THERAPEUTICS INC Filed Acc 0001209191-23-007511
Options or other derivatives
- Chief R&D Officer acquired 450,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Valamehr Bahram Chief R&D Officer | 2023-02-06 | Grant or award · Stock Option (Right to Buy) | +450,000 | 450,000 | D | ||
Loading xslF345X03/doc4.xml…